MedTrace Logo

Amino Acid Transporter System PET/CT Imaging in AATS-Related Diseases

NCT07379463 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-01-30

No results posted yet for this study

Summary

To evaluate the potential usefulness of 11C/18F-MET/FET positron emission tomography/ computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various amino acid transporter system (AATS)-related disease patients.

Conditions

  • Amino-Acid Transport Disorder
  • Primary Hyperparathyroidism
  • Glioma

Interventions

DIAGNOSTIC_TEST

11C/18F-MET/FET

Each subject receive a single intravenous injection of 11C/18F-MET/FET, and undergo PET/CT imaging within the specificed time

Sponsors & Collaborators

  • Tianjin Medical University General Hospital

    collaborator OTHER

  • Tianjin Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-29
Primary Completion
2033-08-29
Completion
2033-08-29

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07379463 on ClinicalTrials.gov